OR WAIT null SECS
© 2021 MJH Life Sciences and Pharmaceutical Technology. All rights reserved.
© 2021 MJH Life Sciences™ and Pharmaceutical Technology. All rights reserved.
Sponsors should consider best practices for maintaining data associated with analytical testing.
Complex biotherapeutics present unique analytical challenges for developers.
Key questions to ask before starting a method development project.
November 24, 2021
MilliporeSigma’s new ColorWheel flow cytometry portfolio is designed to create antibodies and dyes analogous to a primary conjugated antibody.
November 19, 2021
Sartorius’ newly redesigned vacuum filtration units are designed to allow for faster and higher-capacity filtration while offering enhanced stability for sample processing.
November 18, 2021
Lonza is expanding its microbial development capabilities at its Visp, Switzerland, site to support clinical and commercial drug development programs.
November 16, 2021
Synthace has raised $35 million in funding to fuel growth of its life sciences R&D technology.
November 10, 2021
Part 2—Industry experts from MilliporeSigma, Lonza, Astrea Bioseparations, and Sartorius provide insight and examples about solving critical challenges in both analytics and process development for emerging therapies.
November 08, 2021
Part 1—Industry experts from MilliporeSigma, Lonza, Astrea Bioseparations, and Sartorius discuss key issues affecting the development of emerging biotherapies.
November 04, 2021
The partnership between Waters and Sartorius aims to accelerate speed and increase accuracy in bioprocessing analysis.
Gentronix has expanded it lab facilities and increased capacity for genetic, ocular, and skin toxicology testing.
November 03, 2021
Thermo Fisher Scientific showcases its new mass spectrometry and chromatography solutions at the ASMS Conference on Oct. 31–Nov. 4, 2021.
The increased flow of data from laboratory studies requires a data management strategy to optimize study success.